glp-1 drugs and breast cancer Cancer: Science, Safety, and Solutions Researchers from Penn Medicine found
Description
The loss of muscle among older individuals can lead to an increased risk of falls and fractures
Weight loss of this magnitude is transformative for cardiovascular risk
There is reasonable scientific basis to expect that the GLP-1 component will confer similar cardiovascular protection
The FDA has specifically approved Wegovy for chronic weight management , whereas Mounjaro's weight loss benefits are currently considered off-label despite impressive clinical outcomes
The margin between a therapeutic dose and a hypoglycaemic one is narrow
